1. Trang chủ
  2. » Kỹ Thuật - Công Nghệ

Pharmaceutical Substances Syntheses, Patents, Applications - Part 214 pps

10 168 0
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 10
Dung lượng 233,29 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

methyl Trade Names: D: Pelerol Sandoz-comb.; F: Palerol Salvoxyl-Wander; Tropenziline bromide bromide... CN: la,3~,5a-3-[hydroxydiphcnylacetyloxy]spiro[8-azoniabicyclo[3.2.1]octane-8,1

Trang 1

Tromantadine T 213 1

Trade Name(s):

D: Angitrit (Nordmark); wfm Etamin (Zeria) USA: Metamine (Pfizer); wfm

J: Amitolen (Hokuriku) Sedalis (Kayaku)

Use: antiviral RN: 53783-83-8 MF: C,6H28N202 MW: 280.41 EINECS: 258-770-0

CN: 2-[2-(climethylamino)ethoxyl-N-tricyclo[3.3.1 l3z']dec- 1-ylacetamide

monohydrochIoride

RN: 41544-24-5 MF: C,,H,,N,O, HC1 MW: 316.87 EINECS: 255-434-5

FH3

0

1 -amino- chloro- 1 -(2-chloroocet-

odamontone ocetyl amido)adamontane

chloride

Tromantodine

Reference(s):

DOS 1 941 218 (Merz & Co.; appl 13.8.1969)

Peteri, D.; Sterner, W.: Arzneim.-Forsch (ANCEAD) 23,577 (1973)

Formula~ion(s): cream 10 mg, 100 mg/lO g; gel 10 mg, 100 mg/lO g; ointment 1 % (as monohydrochloride)

Trade Name(s):

D: Vim-"Merz" (Merz & Co.) Viru-"Merz" Serol (Merz & I: Viruserol (Novartis

RN: 77-86-1 MF: C,H,,NO, MW: 121.14 EINECS: 201-064-4

CN: 2-amino-2-(hydroxymethy1)-1.3-propanediol

HZ Raney-Ni 02N-CHI + H C H O + H ~ ~ o O H H -,

nitro- farm- 2-(hydroxymethy1)-

methane aldehyde 2-nitro-1 ,3-

propanedial

Reference(s):

U S 2 174 242 (Purdue Res Found.; 1939; appl 1937)

electrolytic reduction:

US 2 485 982 (Commercial Solvents Corp.; 1949; appl 1944)

Trometamol

El

Formu/ation(s): amp 7.3 gl20 ml, sol 34.36 gI100 ml

Trang 2

2 132 T Tropenziline bromide

Trade Name(s):

D: Elektrolyt-Konzentrat Tris TRIS 36.34 % Braun (BI Thamacktat (Bellon;

Use: antispasmodic, parasympathomimetic RN: 143-92-0 MF: C,H,oBrNO, MW: 476.41 EINECS: 205-612-3

CN: 3-[(hydroxydiphenylacetyl)oxy]-6-methoxy-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide

methoxy- methyl- dimethyl

succinoldehyde omine ocetonedi-

corboxylote

N o

H ~ C ~ 0 rn H ~ c ' ~ Hz Roney-Ni -+ - 11

ethyl benrilote

H ~ C ~ 0 rn H ~ c ' ~ Hz Roney-Ni ,,,OH 0 0

6-methoxyiropinone (I)

Reference(s):

CH 325 296 (Sandoz; appl 1954)

Stoll, A et a].: Helv Chim Acta (HCACAV) 37,495 (1954); 38, 571 (1955)

methyl

Trade Name(s):

D: Pelerol (Sandoz)-comb.; F: Palerol (Salvoxyl-Wander);

Tropenziline bromide bromide

Trang 3

Tropicamide T 2133

Use: parasympatholytic, mydriatic RN: 1508-75-4 MF: C17H20N202 MW: 284.36 EINECS: 216-140-2

LD,,,: 565 m g k g (M, p.0.);

865 m g k g (R, p.0.)

CN: N-ethyl-a-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide

HCI + y T N

0-ocetyltropoyl

Tropicarnide

u

Reference(s):

US 2 726 245 (Hoffmann-La Roche; 1955; CH-prior 1952)

Fonnulation(s): eye drops 5 mglml, 5 mg10.5 ml

Trade Name(s):

F: Mydriaticum (Merck Sharp Visumidriatic (Pharmec) USA: Tryptar (Armour); wfm

& Dohme-Chibret)

Tropisetron

(ICS-205930)

ATC: A04AA03 Use: antiemetic, antimigraine, 5-HT,- antagonist

RN: 89565-68-4 MF: C17H20N202 MW: 284.36

CN: JH-Indole-3-carboxylic acid endo-8-methyl-8-azabicyclo[3.2.l]oct-3-yl ester

Trang 4

2134 T Trospium chloride

indole-3-

carboxylic ocid (I)

indole-3- corbonyl chloride (11)

1.THF

2 BuLi, THF

11 +

0

H

H

Tropisetron 4

1 ,la-corbonyl- 1 - ( 1 H-indol-3-

diirnidozole y1corbonyl)- 1 H-

irnidozole

Reference(s):

a DE 3 322 574 (Novartis; appl 23.6.1983; CH-prior 29.6.1982)

a,b BE 901 274 (Sandoz A G.; appl 14.12.1984; CH-prior 23.12.1983)

use of serotonin-5-HT-antagoni~ts:

DE 3 724 059 (Sandoz-Patent GmbH; appl 21.7.1987; D-prior 7.8.1986)

b DE 3 445 377 (Sandoz-Patent GmbH; appl 13.12.1984; CH-prior 23.12.1983)

Langlois, M et al.: Eur J Med Chem (EJMCA5) 28, 869 (1993)

Formrtlution(s): amp 2 mg/2 rnl, 5 mg/5 rnl; cps 5 rng

Trade Name(s):

D: Navoban (ASTA Medica GB: Navoban (Novartis

AWD; Novartis Pharma) Pharma)

F: Navoban (Novartis I: Navoban (Novartis

Use: anticholinergic, antispasmodic RN: 10405-02-4 MF: C,,H,,CINO, MW: 427.97 EINECS: 233-875-4

LD50: 11.2 mg/kg (M i.v.); 812 mg/kg (M, p.0.);

15.5 mg/kg(R, i.v.); 1510mg/kg(R, p.0.)

CN: (la,3~,5a)-3-[(hydroxydiphcnylacetyl)oxy]spiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]

chloride

Trang 5

Trovafloxacin mesilate T 2 135

nortropine 1,4-dibromo-

butane

a-chlorodiphenyl-

acetyl chloride

Trospium chloride

L

Reference(s):

DE 1 194 422 (Pfleger; appl 5.3.1963)

Formulation(s): amp 1.2 mg/2 rnl, 2 mg/2 ml; drg 15 mg, 20 mg, 30 mg; f c tabl 5 mg; suppos 0.75 mg, 1

rng

Trade Name(s):

D: Spasrnex (Pfleger) Spasmo-Urgenili

Spasrno-Fyt (Madaus) (Madam)-comb

Spasmo-Rhoival (Byk Trospi-forte (medac)

GuldenIByk Tosse) J: Spasmex (Nikken)

Trovafioxacin mesilate

(CP-992 19; CP-992 19-27)

ATC: JOlMA13 Use: antibacterial

RN: 147059-75-4 MF: C,,H,,F3N4O, CH403S MW: 512.47

CN: (1 a,5a,6~)-7-(6-Arnino-3-azabicyclo[3.1 O]hex-3-yl)-l-(2,4-difluorophenyl)-6-fluoro- l,4-dihydro-4-0x0-

1,8-naphthyridine-3-carboxylic acid

monohydrate

RN: 193478-08-9 MF: C2,H,,F3N403 CH401S H 2 0 MW: 530.48

base

RN: 147059-72-1 MF: C,,H,,F3N403 MW: 416.36

hydrochloride

RN: 146961-34-4 MF: C2,H,,F3N4O3 IICI MW: 452.82

1 Et,O

O 2 thermolysis -N,

N-benzyl- ethyl

rnoleimide (I) diazoacetate (11)

ethyl ( l a , 5 a , 6 n ) - 3 - benzyl-2,4-dioxo-3- azabicyclo[3.1 O]hexone-

Trang 6

21 36 T Trovafloxacin mesilate

1 LiAIH4, THF 1 CI-Cbo , dioxone, NaHC03

2 Hz, Pd-C, CHJOH H 2 Jones reagent acetone

I -b H 0 / ' " ' ' q N b I V

H benzyl chloroformote

(la,Sa,6a)-3-(benzyl-

oxycorbonyl)-3-020-

bicyclo[3.l O]hexone-

6-carboxylic acid (N)

N3

2 Hz, Pd-C CH30H CH3 H H

b B~~'"‘Q diphenylphosphoryl azide

H

ethyl 7-chloro-1-(2.4-

difluorophenyl)-6-fluoro-

4-0x0-1,4-dihydro- l,8-

nophthyridine-3-corboxylote (W)

@ alternative synthesis of N

VII + H 3 C - S 0 3 H +

separation of diastereorners , H3CAOq 0 ?

H N , c b o

dihydro- carbony1)-

pyrral 2.5-dihydro-

F

H

H2N,,,, 2

H3c-s03H

H P N ,N

F

0 Trovofloxocin rnesilate

-

Trang 7

Trovafloxacin mesilate T 2 137

NaOH

I + N

@) alternative synthesis of V

H 0 1 BH3 THF

H O2N.,,,qN47 2 H, ~ d - c

0

brornonitro

methane

1 Boc\O/Boc, THF TEA

HJ+,,,+;~ 2 HZ Pd-c cH30H

H"" \

Reference(s):

route for trovajloxacin 6P- diastereomer:

Vilsmaier, E.; Goerz: Synthesis (SYNTBF) 739 (1998)

a US 5 164 402 (Pfizer Inc., 17.1 1.1992; USA-prior 11.7.1990)

Brighty, K.E et al.: Synlett (SYNLES) 1996, 1097

JP 09 012 546 (Chisso Corp.; appl 23.6.1995)

aa Braish, T.E et al.: Synlett (SYNLES) 1996, 1100

Stille, J.K et al.: J Org Chem (JOCEAH) 45 (1 I), 2139-2145 (1980)

ES 2 095 809 (Quimica Synth.; appl 27.7.1995)

ab EP 818 445 (Pfizer Inc.; appl 1.7.1997; USA-pr~or 9.7.1996)

starting material VI:

US 4 571 396 (Warner Lambert Co.; 18.2.1986; USA-prior 16.4.1984)

US 4 775 668 (Pfizer Inc.; 4.10.1988; USA-prior 19.8.1986)

novel crystal forms:

W 0 9 639 406 (Pfizer Inc.; USA-prior 6.6.1995)

W 0 9 707 800 (Pfizer Inc.; appl 29.7.1996; USA-prior 29.8.1995)

polymorphs of the prodrug:

WO 9 708 191 (Pfizer Inc.; appl 5.7.1996; USA-prior 29.8.1995)

suspension for oral administration:

DE 19 706 978 (U Posanski; appl 5.1.1998; D-prior 21.2.1997)

use for treatment of Heliobacter pylori infections:

EP 676 199 (Pfizer Inc.; appl 23.3.1995; USA-prior 7.4.1994)

Formulation(s): tabl 100 mg, 200 mg (as mesylate); vials, 40 ml, 6 0 ml with 5 mglml

Trade Narne(s):

D: Trovan (Pfizer); wfm Turvel (Pfizer); wfm USA: Trovan (Pfizer; 1998); wfm

Trang 8

2138 T Troxerutin

- - -

Use: vein therapeutic RN: 7085-55-4 MF: C13HJ20L9 MW: 742.68 EINECS: 230-389-4

LDS,,: 27.16 gtkg (R, i.p.)

CN: 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-0-(6-deoxy-a-~-rnannopyranosy1)-~-~-glucopyranosyl]oxy]- 5-hydroxy-7-(2-hydroxyethoxy)-4H-l-benzopyran-4-one

DAS 1 06 1 327 (Zyma; appl 30.12.1957; CH-prior 4.7.1957)

GB 833 174 (Zyma S.A.; appl 27.6.1958; CH-prior 4.7.1957)

synthesis with cthylcne oxide:

DAS 1 543 974 (Zyma; appl 8.10.1966; F-prior 25.10.1965; CH-prior 9.3.1966)

DAS 1 793 746 (Zyrna; appl 8.10.1966; F-prior 25.10.1965)

Formulation(s): cps 300 rng; eye drops 50 mgtml; f c drg 300 rng; f c tabl 250 rng, 300 rng; s r tabl 300

rng

Trade Name(s):

D: Drisi-Ven (Sertiirner)

Pherarutin (Kanoldt)

Posorutin (Ursapharm) F:

Troxerutin-ratiopharrn

(ratiopharm)

Troxeven (Kreussler)

Vastribil (Farmasan)

Veno SL 300 (Ursapharrn)

GB :

numerous combination preparations

Ginkor (Beaufour)-comb

RhCobral (Niverpham) RhCoflux (Niverpharrn) Veinarnitol (Negma) VivCne (Labs de L' ACrocid) Paroven (Zyma); wfm

I: Derrnoangiopan (Abiogen Pharrna)-comb

Ernorril (Po1i)-comb

Flebil (Molteni) Premium (Synthelab0)- comb

Venolen (Farrnacologico Milanese)

Troxipide

RN: 99777-81-8 MF: C,,H2,N204 MW: 294.35

CN: (k)-3,4,5-trirnethoxy-N-3-piperidinylbenzarnide

ATC: A02BXI I

Usc: ulcer therapeutic

base

RN: 30751-05-4 MF: C15H2,N204 MW: 294.35

LDsu: 100 rng/kg (M, i.v.); 2 g/kg (M, p.0.);

21 00 rnglkg (R, p.0.)

Trang 9

monohydrochloride

RN: 3075 1-03-2 MF: C,SH,,N,04 HCI MW: 330.8 1

LDso: 300 mglkg (M, i.p.); 2000 mglkg (M, p.0.); 1550 mglkg (M, s.c.);

340 m d k g (R, i.p.); 21 00 m g k g (R, p.0.)

3-amino- 3.4.5-trimethoxy- 3-(3.4.5-trimethoxy-

pyridine benzoyl chloride benzamid0)pyridine

Reference(s):

DOS 1 938 512 (Kyorin; J-prior 30.6.1969)

DOS 1 967 324 (Kyorin; J-prior 30.6.1969)

US 3 647 805 (Kyorin; 7.3.1972; appl 1 1.7.1969)

Irikura, T et al.: J Med Chem (JMCMAR), 14, 357 (1971)

medical use for treatment ofgastritis:

EP 254 068 (Kyorin; appl 25.6.1987; J-prior 26.6.1986)

Form~dation(s): tabl 50 rng, 100 rng

Trade Name(s):

J: Aplace (Kyorin; 1986)

ATC: N06AX02 Use: antidepressant, essential amino acid RN: 73-22-3 MF: CI,Hl2N2O, MW: 204.23 EINECS: 200-795-6

LD,,: >16 g k g (R, p.0.)

CN: L-tryptophan

acrolein diethyl ocetomido-

molonoie

H

Trang 10

racemization of N-ocetyl-D-tryptophan

3-cyano-

propian-

aldehyde

3-(5-hydantoiny1)-

propionaldehyde ( N )

5-(3-indoly1rnethyl)- hydantoin

aminaocylase

0 0 COOH

DL-tryptophan (V)

Reference(s1:

a Warner, O.T.; Moe, O.A.: J Am Chem Soc (JACSAT) 70,2765 (1948)

b Komachiya, Y et al.: Nippon Kagaku Kaishi (NKAKB8) 86, 856 (1965)

erlzyrnatic rueenlate resolution:

Chibata, I et al.: Bull Agric Chem Soc Jpn (BACOAV) 21,58, 304 (1957)

purification:

U S 5 057 615 (Mitsui Toatsu; 15.10.1991; J-prior 27.6.1989)

combination with beta blocking agents:

IJS 4 161 530 (Ciba-Gcigy; 17.7.1979; CH-prior 6.1.1975)

GR 1 53 1 091 (Ciba-Gcigy; appl 5.1.1976; CH-prior 6.1.1975)

Volk, W et a].: Arzneim.-Forsch (ANCEAD) 28 (II), 1798 (1978)

newer syntheses for DL-tryptophan:

Hengartner, M et al.: J Org Chem (JOCEAH) 44, 3748 (1979)

Fbrtnulation(s): f c tabl 500 mg; tabl 500 mg

Trade Narne(s):

D: Ardey tropin (Ardeypharm) Actitonic (Reygagne)- Tryptacin (Arther); wfm

Lypharm (esparma) GB: Optimax (Merck)-comb Control Products); wfm numerous combination J : Eltrip (Ono) Tryptophane (Nature's

F: Actitonic (Amido; as DL- USA: Trofan (Upsher-Smith); Tryptophane (Solgar); wfm

Ngày đăng: 02/07/2014, 02:20

TỪ KHÓA LIÊN QUAN